Page results
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
EMIS outage caused backlog of result messages via Keystone
-
This page provides information about the Palliative care and symptom control team
-
Contact details of clinical lead adults and lead paediatrics
-
This patient information explains an inguinal gonadectomy.
-
This patient information explains laparoscopic gonadectomy.
-
Information about hyperthermic intraperitoneal chemotherapy (HIPEC), including about the risks and benefits, and alternatives to the treatment.
-
The British Medical Association (BMA) has announced that junior doctors will take strike action for five days from Saturday 24 February to Wednesday 28 February.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0216 - Inventory management system
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust
-
FOI/2022/0246 - Adult haematology services
-
FOI/2022/0247 - Care Axial SpA referrals to rheumatology
-
FOI/2022/0249 - Robotic process automation/ intelligent automation technology
-
FOI/2022/0263 - Rheumatology prescriptions